Answer
Risankizumab is contraindicated in patients with hypersensitivity to risankizumab or any excipient, or clinically important active infections, such as active tuberculosis.
Sources for this answer
- Skyrizi 150 mg solution for injection in pre-filled penAbbVie Ltd · emc · SmPC §4.3 Contraindications · Version 12Document updated
Sources checked